Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

481
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
481
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

795
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
795
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

936
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
936
Hypertension I: Introduction01:28

Hypertension I: Introduction

743
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
743
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

2.5K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intermittent exposure to high-altitude work: nocturnal hypoxemia sea-level anthropometric and biochemical markers.

Sleep & breathing = Schlaf & Atmung·2026
Same author

Home blood pressure trajectories during 3 months of continuous positive airway pressure therapy in sleepy vs. non-sleepy patients.

Annals of the American Thoracic Society·2026
Same author

Recent Advances in Sleep and Circadian Characteristics in Eating Disorders: A Systematic Review of the Last Five Years (2020-2025).

Nature and science of sleep·2026
Same author

Insomnia and Cardiovascular Disease: Untangling a Complex Relationship.

Journal of sleep research·2026
Same author

Understanding the impact of sleep on cardiovascular risk estimation: comparison of LS7 and LE8 performances in a European population.

American journal of preventive cardiology·2026
Same author

Clinical validation of a multisensor wearable device (SOUNDI) for the diagnosis of obstructive sleep apnea (OSA).

Scientific reports·2026

Related Experiment Video

Updated: Jan 16, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.4K

Refractory hypertension and obstructive sleep apnea.

Grace Oscullo1,2,3, Martino F Pengo4,5, Jose Daniel Gómez-Olivas1,2,3

  • 1Pneumology Department, Hospital Universitario y Politécnico La Fe. Valencia. Spain.

Journal of Hypertension
|October 2, 2025
PubMed
Summary

Refractory hypertension (RfH) is linked to sleep apnea syndrome (OSA). Treating OSA with CPAP significantly lowers blood pressure in RfH patients, improving cardiovascular risk.

Keywords:
obstructive sleep apnearefractory hypertensionresistant hypertension

More Related Videos

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

20.5K
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

3.3K

Related Experiment Videos

Last Updated: Jan 16, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.4K
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

20.5K
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

3.3K

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Hypertension Research

Background:

  • Refractory hypertension (RfH) is a severe form of high blood pressure with elevated cardiovascular risks, affecting 0.5-1% of hypertensive patients.
  • Sleep apnea syndrome (OSA), characterized by airway obstruction during sleep, is highly prevalent globally.
  • Both RfH and OSA involve sympathetic nervous system hyperactivation, suggesting a shared pathophysiological pathway.

Purpose of the Study:

  • To investigate the clinical relationship between refractory hypertension and sleep apnea syndrome.
  • To explore the impact of OSA treatment on blood pressure control in patients with RfH.

Main Methods:

  • Observational studies and clinical trials examining patients with RfH.
  • Assessment of OSA prevalence in RfH populations.
  • Evaluation of blood pressure reduction following continuous positive airway pressure (CPAP) therapy for OSA in RfH patients.

Main Results:

  • A high prevalence of OSA (80-90%) is observed in patients diagnosed with RfH.
  • Continuous positive airway pressure (CPAP) treatment for OSA demonstrates a significant reduction in blood pressure, typically 8-10 mmHg, in patients with RfH.
  • This suggests OSA may contribute to treatment resistance in hypertension.

Conclusions:

  • Sleep apnea syndrome is a common comorbidity in patients with refractory hypertension.
  • Effective treatment of OSA with CPAP can improve blood pressure control and potentially reduce cardiovascular risk in this patient group.